1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neovasc Inc (NVCN)
  7. News

NVCN

Neovasc News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0309 -4.54% 0.6501 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.6766 0.6388 0.6884 0.6516 0.681
more quote information »

Recent News

Date Time Source Heading
12/01/202109:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/01/202109:05GLOBENeovasc to Participate in Sidoti December Virtual Microcap..
12/01/202106:15TRMNH.C. Wainwright Reaffirms Their Buy Rating on Neovasc (NVCN)
11/30/202110:37EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/30/202109:40GLOBENeovasc Reducer™ System Receives National Reimbursement in..
11/24/202114:46EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/24/202113:45SEEKNeovasc granted additional 180 days to regain Nasdaq bid..
11/24/202113:24GLOBENeovasc Granted Additional 180 Calendar Day Grace Period for..
11/24/202110:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/24/202109:34GLOBEThe National Institute for Health and Care Excellence of The..
11/09/202116:25SEEKNeovasc EPS beats by $0.01, beats on revenue
11/09/202116:21GLOBENeovasc Announces Third Quarter 2021 Financial Results and..
11/09/202116:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/09/202116:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/08/202117:35SEEKNeovasc Q3 2021 Earnings Preview
11/01/202109:36EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/01/202109:05GLOBENeovasc to Report Third Quarter 2021 Financial Results on..
10/21/202109:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/21/202109:05GLOBENeovasc Reducer™ Featured in Polish Heart Journal
9/28/202109:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/28/202109:05GLOBENeovasc REDUCER-I Study Published in EuroIntervention..
9/23/202109:05GLOBENeovasc to Participate in 2021 Benzinga Healthcare Small Cap..
9/16/202109:54EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202109:05GLOBENeovasc Announces FDA Approval of COSIRA-II Clinical Trial
8/30/202116:05GLOBENeovasc to Participate in H.C. Wainwright & Co. 23rd Annual..
8/17/202109:05GLOBENeovasc Announces Submission of COSIRA-II Protocol..
8/16/202106:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/10/202116:05GLOBENeovasc Announces Second Quarter 2021 Financial Results
7/27/202109:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/27/202109:05GLOBENeovasc to Report Second Quarter 2021 Financial Results on..
7/13/202109:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/13/202109:05GLOBENeovasc Announces New Appointments in Regulatory and..
6/21/202106:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/18/202109:05GLOBELargest Real-World Registry Supporting Neovasc Reducer™..
6/10/202116:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/10/202115:06GLOBENeovasc Provides Corporate Update
6/07/202109:05GLOBENeovasc Reducer System Receives First National Reimbursement..
6/03/202116:45GLOBENeovasc Inc. Reports Results of Annual General Meeting of..
5/26/202106:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/25/202116:22SEEKNeovasc receives non-compliance notification from Nasdaq
5/25/202116:05GLOBENeovasc Receives NASDAQ Notification Regarding Minimum..
5/21/202102:40SEEKNeovasc updates on German litigation on Tiara
5/20/202116:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/20/202116:05GLOBENeovasc Provides Update on German Litigation
5/13/202109:11GLOBENeovasc to Sponsor Symposium on Reducer at EuroPCR
5/10/202109:05GLOBENeovasc Announces First Patient Enrollment in COSIMA Trial
5/06/202116:43SEEKNeovasc EPS beats by $0.05, misses on revenue
5/06/202116:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/06/202116:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/06/202116:05GLOBENeovasc Announces First Quarter 2021 Financial Results
See more news about this stock »


Your Recent History
NASDAQ
NVCN
Neovasc
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.